Skip to content

Preoperative CT-imaging with patient-specific computer simulation in transcatheter aortic valve replacement: a randomized controlled trial.

Preoperative CT-imaging with patient-specific computer simulation in transcatheter aortic valve replacement: a randomized controlled trial. - GUIDE-TAVR

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56189
Enrollment
354
Registered
2022-02-17
Start date
2022-04-26
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic valve stenosis

Interventions

In patients randomized to arm 1, FEops HEARTGuide will be added to routine preoperative CT imaging. Results of the computer modelling will be discussed with TAVR implanting team prior to the procedu

Sponsors

Sint Antonius Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Primary symptomatic severe aortic valve stenosis (defined as an aortic valve area of

Exclusion criteria

Exclusion criteria: - Previous surgical aortic valve replacement - Permanent pacemaker at baseline - Emergency procedure - Poor CT image quality (disabling computer-simulation), for example because of motion artifacts due to the presence of other implanted devices affecting the region of interest - Patient who did not agree to the informed consent and/or refused to participate - Patient unable to understand the informed consent/study

Design outcomes

Primary

MeasureTime frame
Mild to severe PVR

Secondary

MeasureTime frame
New CD (new-onset left bundle branch block, new-onset atrioventricular block) requiring permanent pacemaker (PPM) implantation. Preoperative and final selected valve size, target and final implantation depth, change of preoperative decision, failure to implant valve, MACCE composite endpoint, quality of life, healthcare costs and cost-effectiveness, FFR measurement (on standard MSCT and CAG).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)